TrialTrials2016

Efficacy study of olmesartan medoxomil on coronary atherosclerosis progression and epicardial adipose tissue volume reduction in patients with coronary atherosclerosis detected by coronary computed tomography angiography: study protocol for a randomized controlled trial.

Ying Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.